Skip to content



Jenni Björnulfson

CEO, CFO and Head of IR

CEO since 2023. CFO and Head of IR since 2021.

Born: 1971

Education: Master’s degree in Finance and Managerial economics from Stockholm School of Economics and studies at the Karolinska Institute

Work experience: Extensive financial and industrial background working for many years within the health care sector. Previous positions include being CFO for Promore Pharma and Cinclus Pharma Holding. Prior to that Jenni worked as an equities analyst at ABG Sundal Collier and she has held corporate finance positions at Alfred Berg and Handelsbanken

Holdings: 22,000 shares, 35,000 warrants